Clearside Biomedical, Inc. Quarterly Current Ratio in % from Q1 2017 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Clearside Biomedical, Inc. quarterly Current Ratio history and growth rate from Q1 2017 to Q2 2024.
  • Clearside Biomedical, Inc. Current Ratio for the quarter ending June 30, 2024 was 518 %, a 39.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 518 -343 -39.8% Jun 30, 2024
Q1 2024 558 -270 -32.6% Mar 31, 2024
Q4 2023 610 -216 -26.2% Dec 31, 2023
Q3 2023 726 -110 -13.2% Sep 30, 2023
Q2 2023 861 +287 +50.1% Jun 30, 2023
Q1 2023 828 +336 +68.2% Mar 31, 2023
Q4 2022 826 +451 +121% Dec 31, 2022
Q3 2022 837 +578 +223% Sep 30, 2022
Q2 2022 574 +336 +141% Jun 30, 2022
Q1 2022 492 +287 +140% Mar 31, 2022
Q4 2021 374 +194 +108% Dec 31, 2021
Q3 2021 259 +66.6 +34.6% Sep 30, 2021
Q2 2021 238 +38.3 +19.2% Jun 30, 2021
Q1 2021 205 -26.4 -11.4% Mar 31, 2021
Q4 2020 180 -92.1 -33.9% Dec 31, 2020
Q3 2020 193 -125 -39.4% Sep 30, 2020
Q2 2020 199 -188 -48.6% Jun 30, 2020
Q1 2020 231 -256 -52.5% Mar 31, 2020
Q4 2019 272 -329 -54.8% Dec 31, 2019
Q3 2019 318 -241 -43.2% Sep 30, 2019
Q2 2019 387 -178 -31.5% Jun 30, 2019
Q1 2019 487 -82.4 -14.5% Mar 31, 2019
Q4 2018 601 -6.66 -1.1% Dec 31, 2018
Q3 2018 559 -348 -38.4% Sep 30, 2018
Q2 2018 565 -712 -55.7% Jun 30, 2018
Q1 2018 569 -682 -54.5% Mar 31, 2018
Q4 2017 607 Dec 31, 2017
Q3 2017 908 Sep 30, 2017
Q2 2017 1.28K Jun 30, 2017
Q1 2017 1.25K Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.